vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and PennyMac Mortgage Investment Trust (PMT). Click either name above to swap in a different company.
PennyMac Mortgage Investment Trust is the larger business by last-quarter revenue ($93.6M vs $47.7M, roughly 2.0× IRONWOOD PHARMACEUTICALS INC). PennyMac Mortgage Investment Trust runs the higher net margin — 56.0% vs -4.8%, a 60.7% gap on every dollar of revenue. On growth, PennyMac Mortgage Investment Trust posted the faster year-over-year revenue change (-13.3% vs -47.3%). Over the past eight quarters, PennyMac Mortgage Investment Trust's revenue compounded faster (12.3% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
PennyMac Mortgage Investment Trust is a U.S.-headquartered real estate investment trust specializing in residential mortgage assets. It invests in performing and non-performing mortgage loans, mortgage-backed securities, and credit risk transfer instruments, operating across investment management and mortgage servicing segments in the U.S. housing market.
IRWD vs PMT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $93.6M |
| Net Profit | $-2.3M | $52.4M |
| Gross Margin | — | — |
| Operating Margin | 14.3% | 38.6% |
| Net Margin | -4.8% | 56.0% |
| Revenue YoY | -47.3% | -13.3% |
| Net Profit YoY | -200.9% | 12.5% |
| EPS (diluted) | $0.01 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $93.6M | ||
| Q3 25 | $122.1M | $99.2M | ||
| Q2 25 | $85.2M | $70.2M | ||
| Q1 25 | $41.1M | $44.5M | ||
| Q4 24 | $90.5M | $107.9M | ||
| Q3 24 | $91.6M | $80.9M | ||
| Q2 24 | $94.4M | $71.2M | ||
| Q1 24 | $74.9M | $74.2M |
| Q4 25 | $-2.3M | $52.4M | ||
| Q3 25 | $40.1M | $58.3M | ||
| Q2 25 | $23.6M | $7.5M | ||
| Q1 25 | $-37.4M | $9.7M | ||
| Q4 24 | $2.3M | $46.5M | ||
| Q3 24 | $3.6M | $41.4M | ||
| Q2 24 | $-860.0K | $25.4M | ||
| Q1 24 | $-4.2M | $47.6M |
| Q4 25 | 14.3% | 38.6% | ||
| Q3 25 | 61.8% | 47.4% | ||
| Q2 25 | 53.2% | 24.2% | ||
| Q1 25 | -70.7% | -14.2% | ||
| Q4 24 | 34.8% | 51.1% | ||
| Q3 24 | 28.0% | 32.8% | ||
| Q2 24 | 26.5% | 40.2% | ||
| Q1 24 | 14.7% | 43.6% |
| Q4 25 | -4.8% | 56.0% | ||
| Q3 25 | 32.8% | 58.7% | ||
| Q2 25 | 27.7% | 10.7% | ||
| Q1 25 | -90.9% | 21.8% | ||
| Q4 24 | 2.5% | 43.1% | ||
| Q3 24 | 4.0% | 51.2% | ||
| Q2 24 | -0.9% | 35.7% | ||
| Q1 24 | -5.6% | 64.2% |
| Q4 25 | $0.01 | $0.49 | ||
| Q3 25 | $0.23 | $0.55 | ||
| Q2 25 | $0.14 | $-0.04 | ||
| Q1 25 | $-0.23 | $-0.01 | ||
| Q4 24 | $0.03 | $0.45 | ||
| Q3 24 | $0.02 | $0.36 | ||
| Q2 24 | $-0.01 | $0.17 | ||
| Q1 24 | $-0.03 | $0.39 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | $190.5M |
| Total DebtLower is stronger | — | $1.1B |
| Stockholders' EquityBook value | $-261.8M | $1.9B |
| Total Assets | $396.9M | $21.3B |
| Debt / EquityLower = less leverage | — | 0.58× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | $190.5M | ||
| Q3 25 | $140.4M | $181.0M | ||
| Q2 25 | $92.9M | $108.6M | ||
| Q1 25 | $108.5M | $204.2M | ||
| Q4 24 | $88.6M | $103.2M | ||
| Q3 24 | $88.2M | $102.8M | ||
| Q2 24 | $105.5M | $336.3M | ||
| Q1 24 | $121.5M | $343.3M |
| Q4 25 | — | $1.1B | ||
| Q3 25 | $199.5M | $299.0M | ||
| Q2 25 | $199.3M | $1.2B | ||
| Q1 25 | $199.2M | $968.4M | ||
| Q4 24 | $199.0M | $1.0B | ||
| Q3 24 | $198.8M | $5.2B | ||
| Q2 24 | $198.6M | $5.4B | ||
| Q1 24 | $398.3M | $5.1B |
| Q4 25 | $-261.8M | $1.9B | ||
| Q3 25 | $-264.2M | $1.9B | ||
| Q2 25 | $-308.2M | $1.9B | ||
| Q1 25 | $-334.1M | $1.9B | ||
| Q4 24 | $-301.3M | $1.9B | ||
| Q3 24 | $-311.3M | $1.9B | ||
| Q2 24 | $-321.7M | $1.9B | ||
| Q1 24 | $-330.5M | $2.0B |
| Q4 25 | $396.9M | $21.3B | ||
| Q3 25 | $396.1M | $18.5B | ||
| Q2 25 | $342.9M | $16.8B | ||
| Q1 25 | $327.2M | $14.9B | ||
| Q4 24 | $350.9M | $14.4B | ||
| Q3 24 | $389.5M | $13.1B | ||
| Q2 24 | $395.6M | $12.1B | ||
| Q1 24 | $438.8M | $12.3B |
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.16× | ||
| Q2 25 | — | 0.65× | ||
| Q1 25 | — | 0.51× | ||
| Q4 24 | — | 0.52× | ||
| Q3 24 | — | 2.70× | ||
| Q2 24 | — | 2.76× | ||
| Q1 24 | — | 2.60× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $-7.2B |
| Free Cash FlowOCF − Capex | $74.6M | — |
| FCF MarginFCF / Revenue | 156.3% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | -137.76× |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $-7.2B | ||
| Q3 25 | $47.6M | $-1.3B | ||
| Q2 25 | $-15.1M | $-2.0B | ||
| Q1 25 | $20.0M | $-594.3M | ||
| Q4 24 | $15.2M | $-2.7B | ||
| Q3 24 | $9.9M | $-983.8M | ||
| Q2 24 | $33.5M | $243.8M | ||
| Q1 24 | $45.0M | $-342.4M |
| Q4 25 | $74.6M | — | ||
| Q3 25 | $47.6M | — | ||
| Q2 25 | $-15.1M | — | ||
| Q1 25 | $19.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $9.9M | — | ||
| Q2 24 | $33.4M | — | ||
| Q1 24 | $44.9M | — |
| Q4 25 | 156.3% | — | ||
| Q3 25 | 39.0% | — | ||
| Q2 25 | -17.7% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.8% | — | ||
| Q2 24 | 35.4% | — | ||
| Q1 24 | 60.0% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | — | -137.76× | ||
| Q3 25 | 1.19× | -22.26× | ||
| Q2 25 | -0.64× | -267.53× | ||
| Q1 25 | — | -61.39× | ||
| Q4 24 | 6.74× | -58.08× | ||
| Q3 24 | 2.71× | -23.76× | ||
| Q2 24 | — | 9.59× | ||
| Q1 24 | — | -7.19× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRWD
Segment breakdown not available.
PMT
| Other | $55.0M | 59% |
| Interest Rate Sensitive Strategies | $31.4M | 34% |
| Correspondent Production | $7.2M | 8% |
